AQEMIA

Inventing New Drugs at Scale with AI and Physics

Paris, France · Founded 2019 · $144.3M raised

Headquarters
Paris
Employees
51–200
Founded
2019
Business Model
B2B
Website
aqemia.com
Total Funding
$144.3M
Last Round
$7.4M GrantApr 2025
Rounds
6

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 6 funding rounds and 6 investors for this company. The full record is or through the API.

About

AQEMIA is a Paris-based pharmatech company founded in 2019 that combines atomic-scale physics algorithms and generative AI to accelerate drug discovery. Its platform, rooted in over 12 years of academic research at CNRS and École Normale Supérieure, eliminates the need for experimental training data to predict drug-target affinities. AQEMIA runs internal and partnered programs in oncology and other high-need therapeutic areas, with collaborations including Sanofi and Servier.

Summary

AQEMIA is an Artificial Intelligence company based in Paris, France, founded in 2019. It has raised $144.3M in total across 6 rounds, most recently a $7.4M Grant round in Apr 2025. Investors include Elaia, Eurazeo and Bpifrance.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantApr 2025
$7.4M

Sign up to see all 6 events

Funding: Pre-Seed through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AQEMIA on Indexed.vc
<a href="https://indexed.vc/companies/aqemia"><img src="https://indexed.vc/api/badge/company/aqemia" alt="AQEMIA on Indexed.vc" width="260" height="76" /></a>